These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12655721)

  • 21. Precision medicine for managing diabetes.
    Klonoff DC
    J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetes, obesity, and Acrp30/adiponectin.
    Hug C; Lodish HF
    Biotechniques; 2002 Sep; 33(3):654, 656, 658 passim. PubMed ID: 12238775
    [No Abstract]   [Full Text] [Related]  

  • 23. Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects.
    Nakatani K; Noma K; Nishioka J; Kasai Y; Morioka K; Katsuki A; Hori Y; Yano Y; Sumida Y; Wada H; Nobori T
    Int J Mol Med; 2005 Jan; 15(1):173-7. PubMed ID: 15583845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
    Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
    J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus in Japan: past, present, and future.
    Eboshida A
    J Diabet Complications; 1991; 5(2-3):49. PubMed ID: 1770049
    [No Abstract]   [Full Text] [Related]  

  • 26. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.
    Mori H; Ikegami H; Kawaguchi Y; Seino S; Yokoi N; Takeda J; Inoue I; Seino Y; Yasuda K; Hanafusa T; Yamagata K; Awata T; Kadowaki T; Hara K; Yamada N; Gotoda T; Iwasaki N; Iwamoto Y; Sanke T; Nanjo K; Oka Y; Matsutani A; Maeda E; Kasuga M
    Diabetes; 2001 Apr; 50(4):891-4. PubMed ID: 11289058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular and therapeutic progress in diabetes: future perspectives].
    Salido E; Hernández D; Torres A
    Nefrologia; 2001; 21 Suppl 3():112-20. PubMed ID: 11642200
    [No Abstract]   [Full Text] [Related]  

  • 28. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.
    Yamauchi T; Kamon J; Ito Y; Tsuchida A; Yokomizo T; Kita S; Sugiyama T; Miyagishi M; Hara K; Tsunoda M; Murakami K; Ohteki T; Uchida S; Takekawa S; Waki H; Tsuno NH; Shibata Y; Terauchi Y; Froguel P; Tobe K; Koyasu S; Taira K; Kitamura T; Shimizu T; Nagai R; Kadowaki T
    Nature; 2003 Jun; 423(6941):762-9. PubMed ID: 12802337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.
    Yamauchi T; Kamon J; Waki H; Terauchi Y; Kubota N; Hara K; Mori Y; Ide T; Murakami K; Tsuboyama-Kasaoka N; Ezaki O; Akanuma Y; Gavrilova O; Vinson C; Reitman ML; Kagechika H; Shudo K; Yoda M; Nakano Y; Tobe K; Nagai R; Kimura S; Tomita M; Froguel P; Kadowaki T
    Nat Med; 2001 Aug; 7(8):941-6. PubMed ID: 11479627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.
    Iwaki M; Matsuda M; Maeda N; Funahashi T; Matsuzawa Y; Makishima M; Shimomura I
    Diabetes; 2003 Jul; 52(7):1655-63. PubMed ID: 12829629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism].
    Kamon J; Yamauchi T; Terauchi Y; Kubota N; Kadowaki T
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):294-300. PubMed ID: 14501164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes. The missing link with obesity?
    Flier JS
    Nature; 2001 Jan; 409(6818):292-3. PubMed ID: 11201721
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans.
    Nemoto M; Sasaki T; Deeb SS; Fujimoto WY; Tajima N
    Diabetes Res Clin Pract; 2002 Aug; 57(2):131-7. PubMed ID: 12062858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics of obesity.
    Damcott CM; Sack P; Shuldiner AR
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):761-86. PubMed ID: 14711061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin resistance physiopathology].
    Boulogne A; Vantyghem MC
    Presse Med; 2004 Jun; 33(10):666-72, 681. PubMed ID: 15257241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.
    Rangwala SM; Rhoades B; Shapiro JS; Rich AS; Kim JK; Shulman GI; Kaestner KH; Lazar MA
    Dev Cell; 2003 Oct; 5(4):657-63. PubMed ID: 14536066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
    Celi FS; Shuldiner AR
    Curr Diab Rep; 2002 Apr; 2(2):179-85. PubMed ID: 12643137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
    Ridker PM; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Plutzky J; Zee RY
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):859-63. PubMed ID: 12663371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin: linking the fat cell to insulin sensitivity.
    Goldfine AB; Kahn CR
    Lancet; 2003 Nov; 362(9394):1431-2. PubMed ID: 14602433
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adiponectin as a key molecule of the metabolic syndrome].
    Funahashi T; Matsuzawa Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():583-92. PubMed ID: 12238103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.